cancer were reported in 2012. Plasma therapeutic products such as immunoglobulin, albumin,
platelets and plasma are widely used for treatment of cancer.
The apheresis market has been segmented as follows:
Increase in number of chronic disease cases and blood donation rate around the globe
expected to support the growth of therapeutic apheresis procedure market in the near future
North America is expected to contribute major market share in apheresis as increase in number of
chronic disorders in this region, such as heart disease, diabetes and arthritis. As per Center for
Disease Control and Prevention (CDC), in 2012, around 117 million adults were suffering from one
or more chronic conditions. Furthermore, in the U.S., out of all adult population, 1 of 4 adult had 2
or more chronic health conditions.
Also, the high growth rate of therapeutic apheresis procedure is expected from Asia Pacific region
in the near future, supported by rise in chronic disorder cases and due to unhealthy habits, such as
feeding on junk food, physical inactivity and poor nutrition habits among rural population.
For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/apheresis-
market-517
Also, the increase in blood donation rate is projected to support the demand for therapeutic
apheresis procedure market in the near future. As per World Health Organization (WHO), in 2013,
112.5 million blood donations were collected globally and around half of these were collected in the
developed countries such as the U.S. and Canada.
Furthermore, the blood donation rate was around 35.0 per 1000 population in developed countries
such as the U.S. and 11.7 per 1000 population in middle-income countries such as India and 4.6 per
1000 population in low-income countries such as Afghanistan. Also, the blood donations rate
increased by 10.7 million in between 2008 to 2013.
Key Players In Apheresis Market Includes:
Some major companies operating in apheresis market are Kawasumi Laboratories Inc., NIKKISO
CO. LTD., Therakos, Inc., Medica S.p.A., Asahi Kasei Medical Co. Ltd., Cerus Corporation, B.
Braun, Melsungen AG, HemaCare Corporation, Haemonetics Corporation and Fresenius Kabi AG.
Apheresis Market, by Procedure:
•Erythrocytapheresis
•Leukapheresis
•Plasmapheresis
•Erythrocytapheresis
•Photopheresis
•LDL-apheresis
Apheresis Market, by Technology:
•Membrane Filtration
•Centrifugation
Apheresis Market, by Application:
•Cancer